BioSpace News Archive

Drug Development

New analysis of patients with autoimmune-related ILDs in the INBUILD study shown as poster presentation at the 2019 ACR/ARP Annual Meeting

Boehringer Ingelheim presented results from a new subgroup analyses that support the primary endpoint results from the Phase III INBUILD® trial that showed Ofev® (nintedanib) reduced the rate of lung function decline in patients with autoimmune-related interstitial lung diseases (ILDs)

November 7, 2019
·
8 min read
Deals

PDI Acquires Majority Share of Tru-D® SmartUVC

Partnership backed by robust clinical evidence, showing value of an integrated approach to infection prevention

November 7, 2019
·
4 min read
Pharm Country

AiCure Raises $24.5 Million Series C Round to Broaden Its Strategic Value for Life Sciences

The investment will accelerate commercial, engineering, and research and development activities in order to advance research-grade data insights for life science companies.

November 7, 2019
·
3 min read
Sierra Oncology Announces Pricing of $103 Million Public Offering of Convertible Preferred Stock and Warrants

The offering is expected to close on November 13, 2019, subject to customary closing conditions.

November 7, 2019
·
5 min read
Business

Sierra Oncology and Gilead Sciences Agree on Amendments to Asset Purchase Agreement for Momelotinib

Gilead to reduce momelotinib commercial royalty rates in exchange for equity in Sierra

November 7, 2019
·
6 min read
Genetown

Capsule Technologies Launches Next Generation Clinical Computing Hub

Capsule Neuron 3 builds on market leading, edge computing for medical device connectivity

November 7, 2019
·
2 min read
Biotech Beach

CorTechs Labs Enters Phase 2 of $1.15 Million NIH Grant to Automate the Diagnosis and Prediction of Alzheimer’s Disease

Phase two of this grant proves CorTechs Labs’ PETQuant™ to be clinically and commercially viable

November 7, 2019
·
3 min read
Genetown

Echosens FAST Score Revolutionizes the Assessment of NASH: Cost-Effective, Efficient Identification of Individuals at Risk for Active Fibrotic NASH

The FAST score is a simple combination of two physical biomarkers: liver stiffness by Vibration Controlled Transient Elastography and Controlled Attenuation Parameter together with aspartate aminotransferase, a circulating biomarker.

November 7, 2019
·
5 min read
Business

South Korean Company, Yuhan Pharmaceuticals Partners with Cyclica to Advance R&D Across Two Separate Programs for Oncology

Yuhan will leverage Cyclica’s integrated drug discovery platform, Ligand DesignTM and Ligand Express® to generate novel chemical entities with desired polypharmacological, physicochemical, and ADMET properties while providing insights into systems biology and structural pharmacogenomics.

November 7, 2019
·
3 min read
Business

Vireo Health Names Bruce Linton as Executive Chairman

He will serve on the board of directors, work closely with Vireo CEO & Founder Kyle Kingsley, M.D., and spearhead the Company’s strategic decision-making, capital markets activity and future partnerships.

November 7, 2019
·
6 min read